RDH54 Antibody

What is Rdh54 and why are antibodies against it important for research?

Rdh54 (also known as Tid1) is a conserved DNA translocase that participates in multiple critical cellular processes including homologous recombination (HR), DNA checkpoint adaptation, and chromosome segregation . It belongs to the Swi2/Snf2 family of ATP-dependent chromatin remodeling factors and shares functional similarities with Rad54. Antibodies against Rdh54 are essential research tools because they enable scientists to detect, quantify, and track this protein in various experimental contexts. By using RDH54 antibodies, researchers can investigate the protein's expression levels, subcellular localization, binding partners, and post-translational modifications. These antibodies are particularly valuable for understanding how Rdh54 contributes to maintaining genome stability and how its dysregulation might lead to genomic instability or increased susceptibility to DNA damage .

How can I verify the specificity of an RDH54 antibody?

Verifying antibody specificity is crucial for obtaining reliable research results. For RDH54 antibodies, several complementary approaches should be employed. First, perform Western blot analysis comparing wild-type cells with rdh54Δ mutant strains to confirm the absence of signal in the deletion mutant. Second, conduct immunoprecipitation experiments followed by mass spectrometry to verify that the antibody primarily pulls down Rdh54 rather than cross-reacting with other proteins. Third, use epitope-tagged versions of Rdh54 (such as FLAG-tagged Rdh54 as mentioned in the search results) and compare detection with both anti-RDH54 and anti-tag antibodies . A fourth validation approach involves immunofluorescence microscopy to confirm that the staining pattern aligns with the expected subcellular localization of Rdh54, particularly after DNA damage when it should be recruited to DNA break sites. Finally, competition assays using purified Rdh54 protein can further confirm specificity by demonstrating signal reduction when the antibody is pre-incubated with its target antigen.

What are the best experimental conditions for using RDH54 antibodies in Western blotting?

For optimal Western blot detection of Rdh54, several key parameters should be considered. Protein extraction should be performed using methods that preserve protein integrity while efficiently lysing yeast cells, such as mechanical disruption with glass beads in the presence of protease inhibitors. Given that Rdh54 is a relatively large protein (approximately 110 kDa), use lower percentage (6-8%) SDS-PAGE gels to achieve better resolution. For transfer to membranes, longer transfer times or semi-dry transfer methods may improve efficiency for this large protein. Blocking should be performed with 5% non-fat milk or BSA in TBST, with overnight primary antibody incubation at 4°C using dilutions typically ranging from 1:500 to 1:2000 (though optimal dilution should be determined empirically). When developing the blot, be aware that phosphorylation or other post-translational modifications may alter Rdh54's migration pattern, potentially resulting in multiple bands or shifts in apparent molecular weight, particularly after DNA damage induction . If signal is weak, consider signal enhancement methods such as chemiluminescence substrates with extended sensitivity or alternative detection systems like fluorescently-labeled secondary antibodies.

How can I use RDH54 antibodies to study protein-protein interactions?

RDH54 antibodies are valuable tools for investigating Rdh54's interactions with partner proteins, particularly within the homologous recombination pathway. Co-immunoprecipitation (Co-IP) represents the most straightforward approach, where cell lysates are incubated with RDH54 antibodies to pull down Rdh54 along with its interaction partners. Based on the search results, key interaction partners to investigate include Rad51, Rad53, and potentially Rad54 . When designing Co-IP experiments, consider using mild lysis conditions (e.g., NP-40 or Triton X-100 based buffers) to preserve protein complexes. For detecting transient or weak interactions, consider using crosslinking agents before lysis. Proximity ligation assays (PLA) offer an alternative approach for visualizing protein-protein interactions in situ, requiring specific antibodies against both Rdh54 and its potential interaction partners. For quantitative analysis of binding affinities, surface plasmon resonance or microscale thermophoresis with purified proteins can complement antibody-based approaches. In all cases, controls should include rdh54Δ strains and immunoprecipitation with non-specific antibodies to confirm specificity of detected interactions .

How can I optimize chromatin immunoprecipitation (ChIP) protocols using RDH54 antibodies?

Optimizing ChIP protocols for Rdh54 requires careful consideration of several factors based on the protein's known properties and interactions. From the search results, we know that ChIP has been successfully used to test whether Rdh54 is targeted to HO-induced double-strand breaks (DSBs) . For optimal ChIP performance, first consider crosslinking conditions: standard 1% formaldehyde for 10-15 minutes may be sufficient, but optimization may be necessary given that Rdh54 interacts with both proteins and DNA. Sonication conditions should be carefully optimized to generate DNA fragments of 200-500 bp. For immunoprecipitation, pre-clearing lysates with protein A/G beads can reduce background, followed by overnight incubation with RDH54 antibodies at 4°C.

Based on the search results, Rdh54 recruitment to DSBs is Rad51/Rad52-dependent , suggesting that ChIP experiments should include rad51Δ and rad52Δ strains as important controls. Additionally, using strains with FLAG-tagged Rdh54 and commercial anti-FLAG antibodies has proven effective , which may provide better results than some RDH54 antibodies. When analyzing ChIP data, consider examining both the immediate vicinity of DSBs and regions further away, as Rdh54's DNA translocation activity may affect its distribution along chromatin. For quantitative PCR analysis of ChIP samples, design primers targeting both the break site and control regions, and normalize appropriately using input samples and control genomic regions. Time-course experiments following DSB induction (e.g., using galactose-inducible HO endonuclease systems) can provide valuable insights into the dynamics of Rdh54 recruitment and dissociation from damaged chromatin.

What approaches can be used to study Rdh54 phosphorylation by Rad53 using antibodies?

For identifying specific phosphorylation sites, immunoprecipitate Rdh54 from cells under normal conditions and after DNA damage (which activates Rad53), followed by mass spectrometry analysis. Phos-tag SDS-PAGE followed by Western blotting with RDH54 antibodies can resolve different phosphorylated forms of the protein, revealing changes in phosphorylation patterns under different conditions or in rad53 mutant backgrounds. In vitro kinase assays using purified Rad53 and Rdh54, followed by Western blotting or autoradiography (if using radioactive ATP), can confirm direct phosphorylation. To establish the functional significance of phosphorylation, compare wild-type Rdh54 with phosphomimetic (S/T to D/E) and phosphodeficient (S/T to A) mutants in various assays, including DNA translocation and homologous recombination assays . Throughout these experiments, controls should include rad53 kinase-dead mutants and DNA damage conditions that activate or inhibit Rad53 activity.

How can immunofluorescence with RDH54 antibodies help elucidate Rdh54's spatial organization within the nucleus?

Immunofluorescence microscopy using RDH54 antibodies provides valuable insights into the spatial organization and dynamics of Rdh54 within the nucleus, particularly in relation to DNA repair processes. Based on the search results showing that Rdh54 occupies specific sites within the Rad51 presynaptic complex and has distinct binding properties from Rad54 , immunofluorescence can help visualize these spatial relationships in cellular contexts. To optimize immunofluorescence protocols, cells should be fixed with formaldehyde (typically 3-4%) and permeabilized with appropriate detergents to allow antibody access while preserving nuclear architecture. Since Rdh54 is expected to form foci at sites of DNA damage, experiments should compare untreated cells with those exposed to DNA-damaging agents such as methyl methanesulfonate (MMS), which was used in studies referenced in the search results .

For co-localization studies, combine RDH54 antibodies with antibodies against other recombination proteins such as Rad51, Rad54, and γH2AX (a marker of DNA double-strand breaks). Super-resolution microscopy techniques like structured illumination microscopy (SIM) or stochastic optical reconstruction microscopy (STORM) can provide enhanced resolution to distinguish the precise localization patterns of Rdh54 and its partners within repair foci. Time-lapse imaging in live cells using fluorescently-tagged Rdh54 can complement antibody-based approaches to track the dynamics of Rdh54 recruitment to and dissociation from damage sites. Compare localization patterns in wild-type cells versus cells carrying mutations in Rdh54's N-terminal domain, which the search results indicate is responsible for its unique binding interactions , to further understand the determinants of Rdh54's spatial organization.

What controls are essential when using RDH54 antibodies to analyze mutant phenotypes?

When using RDH54 antibodies to analyze mutant phenotypes, rigorous controls are essential to ensure reliable and interpretable results. First and foremost, include an rdh54Δ strain as a negative control to establish baseline signal and confirm antibody specificity. For studies of Rdh54 mutants, verify expression levels of the mutant proteins relative to wild-type Rdh54 using quantitative Western blotting to ensure that observed phenotypic differences are not simply due to altered protein levels. When studying specific mutants mentioned in the search results, such as the translocation-defective Rdh54-K318R mutant or chimeric proteins like Rad54NRdh54 and Rdh54NRad54 , include controls examining the mutant proteins' stability, subcellular localization, and interaction capabilities.

For functional studies, include controls that distinguish between direct effects of Rdh54 mutations and indirect effects due to altered interactions with partners like Rad51 or Rad53. Based on the search results, rad54Δ strains should be included as controls when studying Rdh54 function, as there are additive growth phenotypes in rad54Δ rdh54Δ yeast strains , indicating partly overlapping functions. When analyzing Rdh54's role in DNA damage response, compare phenotypes across multiple DNA damaging agents, as the search results indicate different sensitivities (e.g., to MMS) . Finally, when using antibodies to track Rdh54 recruitment to chromatin or specific DNA structures, include controls examining recruitment dynamics in the absence of key factors known to affect Rdh54 function, such as Rad51 and Rad52, which the search results indicate are required for Rdh54 recruitment to double-strand breaks .

Why might RDH54 antibodies show unexpected binding patterns in chromatin immunoprecipitation experiments?

Unexpected binding patterns of Rdh54 in ChIP experiments may stem from several factors related to the protein's biology and technical considerations. Based on the search results, Rdh54's recruitment to double-strand breaks depends on Rad51 and Rad52 , so alterations in these proteins might affect Rdh54 binding patterns. Rdh54 possesses DNA translocation activity, potentially causing it to slide away from its initial binding sites, resulting in broader distribution patterns than expected. The search results also indicate that Rad53 kinase activity may regulate Rdh54's translocation on dsDNA , suggesting that the cell's checkpoint status could affect Rdh54's chromatin association patterns.

Technical factors that might contribute to unexpected ChIP results include crosslinking efficiency (over or under-crosslinking), sonication conditions affecting chromatin fragmentation, antibody specificity issues, or PCR amplification biases. To address these concerns, optimize crosslinking time and formaldehyde concentration, verify sonication produces appropriately sized fragments (200-500 bp), and include controls such as ChIP in rdh54Δ strains and with non-specific antibodies. Consider that Rdh54's binding might be cell cycle-dependent or affected by specific DNA structures, warranting synchronized cell populations or specialized DNA damage induction methods. If RDH54 antibodies continue showing inconsistent results, alternative approaches like ChIP using epitope-tagged Rdh54 (FLAG-Rdh54 as mentioned in the search results ) may provide more consistent results while maintaining biological relevance.

How can I distinguish between Rdh54 and Rad54 signals in my experiments?

Distinguishing between Rdh54 and Rad54 signals is crucial given their functional similarities yet distinct roles in homologous recombination. According to the search results, despite biochemical similarities, Rad54 and Rdh54 make different contributions to genome integrity, with rad54Δ strains showing greater susceptibility to DNA damaging agents than rdh54Δ cells . For antibody-based experiments, several approaches can help differentiate between these proteins.

First, validate antibody specificity by Western blotting using extracts from wild-type, rad54Δ, rdh54Δ, and rad54Δ rdh54Δ strains to confirm that each antibody recognizes only its intended target. For immunofluorescence or ChIP experiments, compare signal patterns in wild-type cells versus single and double mutants. The search results indicate that Rad54 and Rdh54 bind to distinct non-overlapping sites within the Rad51-ssDNA presynaptic complex, with their binding site specificities dictated by their N-terminal domains . Exploit this differential localization by designing experiments that can spatially resolve their binding sites, such as high-resolution ChIP-seq or super-resolution microscopy.

In experiments examining protein-protein interactions, the search results indicate that the N-terminal domains of Rad54 and Rdh54 interact with Rad51 , but potentially at different sites. Use competition assays to determine whether the presence of one protein affects antibody detection of the other. For functional studies, the search results show that Rdh54 phenotypes are more severe in diploid yeast , suggesting that comparing haploid and diploid contexts might help distinguish Rdh54-specific functions. Finally, consider using epitope-tagged versions of these proteins with different tags, allowing simultaneous detection and clear distinction in co-localization studies.

What factors might affect the detection of Rdh54 phosphorylation by Rad53?

Detecting Rdh54 phosphorylation by Rad53 presents several challenges that researchers should consider. Based on the search results, Rad53 kinase activity appears to downregulate Rdh54's translocation activity on dsDNA , indicating that this phosphorylation is biologically significant but potentially complex to detect. Several factors may affect successful detection of this phosphorylation.

First, phosphorylation events may be transient or occur on only a small fraction of the total Rdh54 pool, particularly if they are part of a regulatory mechanism that is quickly reversed after serving its purpose. The timing of sample collection after DNA damage or other Rad53-activating events is therefore critical. Second, standard protein extraction methods might not preserve phosphorylation states adequately; samples should be processed rapidly in the presence of phosphatase inhibitors. Third, the specific phosphorylation sites might be located in regions of Rdh54 that are poorly recognized by the antibody or are masked by protein conformational changes after phosphorylation.

To address these challenges, enrich for phosphorylated Rdh54 using phospho-protein enrichment methods before immunoblotting. Consider using Phos-tag SDS-PAGE, which specifically retards the migration of phosphorylated proteins, allowing better separation of phosphorylated and non-phosphorylated forms. For site-specific analysis, custom phospho-specific antibodies targeting Rad53 consensus sites on Rdh54 might be necessary. Additionally, compare phosphorylation patterns under conditions known to activate Rad53 (various DNA damaging agents) versus conditions with inactive Rad53 (checkpoint-deficient mutants). Mass spectrometry analysis of immunoprecipitated Rdh54 remains the gold standard for comprehensive phosphorylation site mapping and quantification, though this approach requires significant optimization for low-abundance modifications.

How should I interpret conflicting data between in vitro and in vivo studies using RDH54 antibodies?

Resolving conflicts between in vitro and in vivo studies using RDH54 antibodies requires careful consideration of the different experimental contexts. The search results provide examples of such discrepancies, noting that Rdh54 showed D-loop formation activity in bulk biochemical assays but did not promote target binding in DNA curtain assays . Similarly, chimeric proteins with swapped N-terminal domains (Rad54NRdh54 and Rdh54NRad54) showed different behaviors in biochemical versus cellular assays .

When faced with such discrepancies, first consider methodological differences. In vitro systems use purified components at concentrations that may not reflect cellular conditions, potentially masking concentration-dependent effects or missing essential cofactors. The search results specifically mention that differences between bulk experiments and single-molecule conditions might be due to "increased concentration of donor dsDNA in the bulk reactions (nanomolar) relative to the single-molecule conditions (attomolar)" . Verify antibody behavior in both contexts, as some antibodies perform differently in various applications due to differences in epitope accessibility or protein conformation.

Next, examine the biological complexity. In vivo, Rdh54 exists within a network of interactions and regulatory mechanisms, including phosphorylation by Rad53 , which may not be fully recapitulated in vitro. The search results indicate that "the function of Rad54 is defined by its binding sites within the Rad51 presynaptic complex and is essential for survival during DNA damage response. In contrast, Rdh54 retains function regardless of its relative location" . This contextual dependency might explain different observations across experimental systems.

To reconcile conflicting data, design bridging experiments that incrementally increase system complexity, such as reconstituting multiple-component systems in vitro or using cellular extracts as intermediate complexity models. Consider that both datasets may be valid under their specific conditions, revealing different aspects of Rdh54's multifaceted functions. The apparent contradiction might actually reflect biological plasticity, where Rdh54's activities vary depending on cellular context, interaction partners, or post-translational modifications.

How can RDH54 antibodies be used to investigate the protein's role in meiotic recombination?

RDH54 antibodies offer powerful tools to investigate Rdh54's specialized roles in meiotic recombination. The search results indicate that "rdh54 phenotypes are more severe in diploid yeast, suggesting that it may play more prominent roles in mitotic and meiotic HR reactions that utilize the homolog rather than the sister as a donor template" . This finding points to Rdh54's particular importance in meiosis, where homolog-directed recombination is essential for proper chromosome segregation.

To investigate Rdh54's meiotic functions, immunofluorescence microscopy with RDH54 antibodies can track the protein's localization throughout meiotic progression, particularly in relation to sites of programmed double-strand breaks marked by Spo11 or other meiotic recombination proteins. ChIP followed by sequencing (ChIP-seq) using RDH54 antibodies can map genome-wide binding sites during meiosis, potentially revealing preferences for certain chromosome regions or recombination hotspots. Comparing these patterns between wild-type cells and mutants defective in various steps of meiotic recombination (spo11Δ, dmc1Δ, etc.) can position Rdh54's function within the meiotic recombination pathway.

Co-immunoprecipitation experiments with RDH54 antibodies during meiosis may identify meiosis-specific interaction partners not detected in mitotic cells. The search results mention that Hed1, a meiosis-specific protein, inhibits Rad54 binding to Rad51-ssDNA but has less effect on Rdh54 , suggesting differential regulation of these related proteins during meiosis. Investigating how Hed1 affects Rdh54 activity could provide insights into meiosis-specific roles. Combine these approaches with genetic analysis of rdh54 mutants specifically in meiosis, examining crossover formation, non-crossover formation, and chromosome segregation to comprehensively understand Rdh54's contributions to meiotic genome stability.

What techniques can be used to study the dynamic interaction between Rdh54 and Rad51 using antibodies?

Studying the dynamic interaction between Rdh54 and Rad51 requires techniques that can capture both spatial and temporal aspects of their relationship. The search results indicate that Rdh54 interacts with the Rad51 presynaptic complex at specific sites distinct from Rad54's binding sites , making this interaction particularly interesting to investigate. Several antibody-based approaches can provide insights into this dynamic relationship.

Förster resonance energy transfer (FRET) combined with antibodies can detect close associations between Rdh54 and Rad51 in fixed cells. This approach requires primary antibodies against each protein followed by secondary antibodies labeled with appropriate FRET pairs. Alternatively, proximity ligation assay (PLA) using specific antibodies against Rdh54 and Rad51 can visualize their interaction with high sensitivity, generating fluorescent signals only when the proteins are within 40 nm of each other.

For temporal dynamics, design time-course experiments following DNA damage induction, using co-immunoprecipitation with either RDH54 or RAD51 antibodies at different time points to track changes in complex formation. The search results suggest a model where "Rdh54 activity at DNA repair sites is controlled by a dynamic equilibrium that balances recruitment of Rdh54 by Rad51 and dissociation of Rdh54 through translocation along dsDNA" . To test this model, combine ChIP-sequencing at different time points after damage with biochemical assays measuring Rdh54's translocation activity.

Single-molecule approaches can provide particularly detailed insights. While not directly antibody-based, findings from single-molecule studies mentioned in the search results can guide the design of bulk experiments using antibodies. For instance, immunoprecipitation of Rdh54 followed by mass spectrometry at different stages of DNA repair could identify changes in the composition of Rdh54-associated complexes that might reflect its dynamic association with and dissociation from Rad51.

How can I use antibodies to study the role of Rdh54's N-terminal domain in determining its function?

The search results highlight the critical importance of Rdh54's N-terminal domain (NTD) in determining its specific functions, noting that "binding site specificities are dictated by their N-terminal domains" and that chimeric proteins with swapped NTDs redirect the proteins to incorrect sites. Several antibody-based approaches can elucidate the role of Rdh54's NTD in determining its function.

First, generate or obtain antibodies specifically targeting the NTD of Rdh54 to directly monitor this domain in various contexts. Compare the binding patterns of these domain-specific antibodies with antibodies recognizing the full-length protein to determine whether conformational changes or protein interactions might mask the NTD under certain conditions. For studying NTD-mediated protein interactions, use the NTD-specific antibodies in co-immunoprecipitation experiments to identify proteins that specifically interact with this domain.

Create a panel of yeast strains expressing Rdh54 variants with point mutations or small deletions within the NTD, then use RDH54 antibodies to compare their expression, stability, subcellular localization, and chromatin association patterns. The search results describe experiments with chimeric proteins (Rad54NRdh54 and Rdh54NRad54) , which could be further analyzed using antibodies to determine how swapping the NTDs affects post-translational modifications, protein stability, or interaction patterns.

Structural studies combined with antibody epitope mapping can provide insights into the NTD's conformation and accessibility in different functional states. Using antibodies that recognize specific epitopes within the NTD, determine whether these epitopes become more or less accessible under different conditions or in the presence of interaction partners like Rad51. Finally, for in vivo functional studies, combine genetic analysis of NTD mutants with immunofluorescence or ChIP to correlate changes in Rdh54's localization or chromatin association with functional outcomes in DNA repair and recombination.

What are the most promising future directions for RDH54 antibody-based research?

Several promising future directions emerge for RDH54 antibody-based research, building on the findings described in the search results. One significant avenue involves investigating the regulation of Rdh54 by phosphorylation. The search results indicate that "Rad53 whose kinase activity appears to down regulate the translocation activity of Rdh54 on dsDNA" . Developing and utilizing phospho-specific antibodies that recognize Rdh54 phosphorylated at specific sites would enable researchers to track this regulatory mechanism in vivo and correlate it with functional outcomes in DNA repair and recombination.

Another promising direction involves exploring Rdh54's role in specialized recombination contexts. The search results mention that "Rdh54 has also been implicated in template switching during break-induced replication (BIR)" and that its phenotypes are more severe in diploid yeast. Using RDH54 antibodies to study its behavior during BIR, meiotic recombination, or recombination between homologous chromosomes rather than sister chromatids could reveal context-specific functions and regulations.

Single-cell analyses represent another frontier. Combining RDH54 antibodies with single-cell technologies such as imaging mass cytometry or single-cell Western blotting could reveal cell-to-cell variability in Rdh54 expression, modification states, or localization patterns, potentially uncovering subpopulations with distinct repair capacities or vulnerabilities to genomic instability.

The search results describe a "dynamic equilibrium that balances recruitment of Rdh54 by Rad51 and dissociation of Rdh54 through translocation along dsDNA" . Developing quantitative microscopy approaches using antibodies to track this equilibrium in real-time could provide insights into the kinetics and regulation of DNA repair processes. Finally, extending RDH54 antibody studies to mammalian homologs would establish whether the mechanisms described in yeast are evolutionarily conserved and potentially relevant to human disease. This could open new avenues for understanding genomic instability in cancer and opportunities for therapeutic intervention targeting these pathways.